

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cGMP biosynthetic process (GO:0006182) | 9.07993510 |
| 2 | cardiac myofibril assembly (GO:0055003) | 7.92111284 |
| 3 | cardiac chamber formation (GO:0003207) | 7.31290942 |
| 4 | positive regulation of urine volume (GO:0035810) | 6.97804678 |
| 5 | * sarcomere organization (GO:0045214) | 6.65208034 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.54732572 |
| 7 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 6.53762975 |
| 8 | cardiac ventricle formation (GO:0003211) | 6.49920170 |
| 9 | myofibril assembly (GO:0030239) | 6.49489128 |
| 10 | potassium ion export (GO:0071435) | 6.33519671 |
| 11 | atrioventricular valve morphogenesis (GO:0003181) | 6.33070857 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 6.13196414 |
| 13 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.03051027 |
| 14 | atrial septum morphogenesis (GO:0060413) | 5.97225873 |
| 15 | cGMP metabolic process (GO:0046068) | 5.96469719 |
| 16 | positive regulation of renal sodium excretion (GO:0035815) | 5.92349406 |
| 17 | cardiac muscle contraction (GO:0060048) | 5.81762637 |
| 18 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 5.78049874 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 5.75532057 |
| 20 | * cardiac muscle hypertrophy (GO:0003300) | 5.75249416 |
| 21 | cell migration involved in heart development (GO:0060973) | 5.62668525 |
| 22 | regulation of urine volume (GO:0035809) | 5.55657996 |
| 23 | atrial cardiac muscle cell action potential (GO:0086014) | 5.47798069 |
| 24 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.43449643 |
| 25 | muscle filament sliding (GO:0030049) | 5.40349271 |
| 26 | actin-myosin filament sliding (GO:0033275) | 5.40349271 |
| 27 | * striated muscle hypertrophy (GO:0014897) | 5.39188000 |
| 28 | * cardiac muscle cell development (GO:0055013) | 5.26430153 |
| 29 | pericardium development (GO:0060039) | 5.22985160 |
| 30 | * cardiac muscle tissue morphogenesis (GO:0055008) | 5.11504281 |
| 31 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.10300376 |
| 32 | carnitine shuttle (GO:0006853) | 5.08966596 |
| 33 | positive regulation of action potential (GO:0045760) | 5.00123942 |
| 34 | cyclic purine nucleotide metabolic process (GO:0052652) | 4.95827094 |
| 35 | * ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.94624429 |
| 36 | regulation of actin filament-based movement (GO:1903115) | 4.92231948 |
| 37 | * cardiac cell development (GO:0055006) | 4.92079794 |
| 38 | fatty acid transmembrane transport (GO:1902001) | 4.91297000 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.90914959 |
| 40 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.87912537 |
| 41 | * muscle hypertrophy (GO:0014896) | 4.80749895 |
| 42 | cyclic nucleotide biosynthetic process (GO:0009190) | 4.77044990 |
| 43 | endocardial cushion development (GO:0003197) | 4.73251438 |
| 44 | 2-oxoglutarate metabolic process (GO:0006103) | 4.71533103 |
| 45 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.70728820 |
| 46 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.69731323 |
| 47 | * striated muscle adaptation (GO:0014888) | 4.67062610 |
| 48 | lysine catabolic process (GO:0006554) | 4.66209674 |
| 49 | lysine metabolic process (GO:0006553) | 4.66209674 |
| 50 | regulation of the force of heart contraction (GO:0002026) | 4.61449326 |
| 51 | regulation of heart rate by cardiac conduction (GO:0086091) | 4.58435282 |
| 52 | glyoxylate metabolic process (GO:0046487) | 4.56008176 |
| 53 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.55353213 |
| 54 | * adult heart development (GO:0007512) | 4.54729264 |
| 55 | * muscle tissue morphogenesis (GO:0060415) | 4.51667536 |
| 56 | actin-mediated cell contraction (GO:0070252) | 4.48897300 |
| 57 | * cardiac muscle adaptation (GO:0014887) | 4.48817248 |
| 58 | * cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.48817248 |
| 59 | * muscle hypertrophy in response to stress (GO:0003299) | 4.48817248 |
| 60 | * regulation of sarcomere organization (GO:0060297) | 4.47478544 |
| 61 | regulation of renal sodium excretion (GO:0035813) | 4.47190335 |
| 62 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.46799558 |
| 63 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.46152854 |
| 64 | regulation of cardioblast proliferation (GO:0003264) | 4.46152854 |
| 65 | response to inactivity (GO:0014854) | 4.45744324 |
| 66 | * heart trabecula formation (GO:0060347) | 4.44736708 |
| 67 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.41223763 |
| 68 | negative regulation of potassium ion transport (GO:0043267) | 4.39917355 |
| 69 | * actomyosin structure organization (GO:0031032) | 4.38860447 |
| 70 | heart process (GO:0003015) | 4.36899287 |
| 71 | heart contraction (GO:0060047) | 4.36899287 |
| 72 | regulation of vascular permeability (GO:0043114) | 4.35319034 |
| 73 | negative regulation of systemic arterial blood pressure (GO:0003085) | 4.32519166 |
| 74 | cardiac conduction (GO:0061337) | 4.26378451 |
| 75 | fatty acid beta-oxidation (GO:0006635) | 4.23701600 |
| 76 | * regulation of cardiac muscle contraction (GO:0055117) | 4.15692819 |
| 77 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.12424329 |
| 78 | aspartate family amino acid catabolic process (GO:0009068) | 4.08730367 |
| 79 | * muscle adaptation (GO:0043500) | 4.08370597 |
| 80 | striated muscle contraction (GO:0006941) | 4.07792189 |
| 81 | cell communication involved in cardiac conduction (GO:0086065) | 4.05358838 |
| 82 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.04556621 |
| 83 | venous blood vessel morphogenesis (GO:0048845) | 4.04519683 |
| 84 | negative regulation of myoblast differentiation (GO:0045662) | 3.98970425 |
| 85 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.97489852 |
| 86 | negative regulation of heart growth (GO:0061117) | 3.97489852 |
| 87 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.97090246 |
| 88 | cellular ketone body metabolic process (GO:0046950) | 3.94363411 |
| 89 | * positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.93052676 |
| 90 | * positive regulation of cardiac muscle cell proliferation (GO:0060045) | 3.88655306 |
| 91 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.88003109 |
| 92 | regulation of excretion (GO:0044062) | 3.84186788 |
| 93 | * regulation of striated muscle contraction (GO:0006942) | 3.81993475 |
| 94 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.81445989 |
| 95 | regulation of cell communication by electrical coupling (GO:0010649) | 3.80774971 |
| 96 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.78709852 |
| 97 | carnitine transmembrane transport (GO:1902603) | 3.78594565 |
| 98 | cardiac septum development (GO:0003279) | 3.77870860 |
| 99 | cell communication by electrical coupling (GO:0010644) | 3.77546276 |
| 100 | regulation of cofactor metabolic process (GO:0051193) | 3.72784763 |
| 101 | regulation of coenzyme metabolic process (GO:0051196) | 3.72784763 |
| 102 | relaxation of cardiac muscle (GO:0055119) | 3.72153377 |
| 103 | regulation of fatty acid oxidation (GO:0046320) | 3.69415952 |
| 104 | regulation of cardioblast differentiation (GO:0051890) | 3.68876271 |
| 105 | fatty acid oxidation (GO:0019395) | 3.66562641 |
| 106 | fatty acid catabolic process (GO:0009062) | 3.65719670 |
| 107 | lipid oxidation (GO:0034440) | 3.59095706 |
| 108 | * regulation of heart contraction (GO:0008016) | 3.59042931 |
| 109 | negative regulation of myotube differentiation (GO:0010832) | 3.57599995 |
| 110 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.54363078 |
| 111 | acetyl-CoA metabolic process (GO:0006084) | 3.53882251 |
| 112 | carnitine transport (GO:0015879) | 3.53324065 |
| 113 | amino-acid betaine transport (GO:0015838) | 3.53324065 |
| 114 | * positive regulation of heart growth (GO:0060421) | 3.52633751 |
| 115 | ATP synthesis coupled proton transport (GO:0015986) | 3.52088812 |
| 116 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.52088812 |
| 117 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.51773186 |
| 118 | L-phenylalanine catabolic process (GO:0006559) | 3.51773186 |
| 119 | succinate metabolic process (GO:0006105) | 3.51614790 |
| 120 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.50538110 |
| 121 | outflow tract septum morphogenesis (GO:0003148) | 3.50400982 |
| 122 | L-phenylalanine metabolic process (GO:0006558) | 3.47504150 |
| 123 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.47504150 |
| 124 | NADH metabolic process (GO:0006734) | 3.47099877 |
| 125 | regulation of ATPase activity (GO:0043462) | 3.46550391 |
| 126 | regulation of ATP catabolic process (GO:1903289) | 3.46550391 |
| 127 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.44744894 |
| 128 | regulation of membrane repolarization (GO:0060306) | 3.44429204 |
| 129 | tricarboxylic acid metabolic process (GO:0072350) | 3.43879160 |
| 130 | oxidative phosphorylation (GO:0006119) | 3.43114225 |
| 131 | detection of calcium ion (GO:0005513) | 3.41759668 |
| 132 | * positive regulation of cardiac muscle tissue development (GO:0055025) | 3.39126163 |
| 133 | cardiac muscle tissue development (GO:0048738) | 3.38719352 |
| 134 | gap junction assembly (GO:0016264) | 3.38455356 |
| 135 | kynurenine metabolic process (GO:0070189) | 3.38183580 |
| 136 | oxaloacetate metabolic process (GO:0006107) | 3.37951751 |
| 137 | actin filament-based movement (GO:0030048) | 3.37940565 |
| 138 | ketone body metabolic process (GO:1902224) | 3.37030783 |
| 139 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.34220710 |
| 140 | carnitine metabolic process (GO:0009437) | 3.33897228 |
| 141 | monocarboxylic acid catabolic process (GO:0072329) | 3.32809394 |
| 142 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.31486661 |
| 143 | plasma membrane repair (GO:0001778) | 3.31408676 |
| 144 | amino-acid betaine metabolic process (GO:0006577) | 3.30887272 |
| 145 | branched-chain amino acid catabolic process (GO:0009083) | 3.29763836 |
| 146 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.29242586 |
| 147 | regulation of sequestering of triglyceride (GO:0010889) | 3.28944288 |
| 148 | respiratory electron transport chain (GO:0022904) | 3.28780463 |
| 149 | regulation of heart rate (GO:0002027) | 3.28606249 |
| 150 | regulation of skeletal muscle contraction (GO:0014819) | 3.25392444 |
| 151 | cardiac muscle cell action potential (GO:0086001) | 3.24058891 |
| 152 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 12.6980976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.11049413 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.68912762 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.23885997 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.75238722 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.41743233 |
| 6 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.16197424 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.79112460 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.59573236 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.59478870 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.44505624 |
| 11 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.02325027 |
| 12 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.02325027 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.00488669 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.66748452 |
| 15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.43256755 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.42602420 |
| 17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.41042824 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.33575563 |
| 19 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.25000490 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.24782947 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.24595731 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.17391932 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.14838326 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.12185053 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03506105 |
| 26 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.89396354 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.89117564 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.88738762 |
| 29 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.77235407 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.65034233 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61298435 |
| 32 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.55692675 |
| 33 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.53296077 |
| 34 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.45945256 |
| 35 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45818436 |
| 36 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.43631851 |
| 37 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.42941022 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42934606 |
| 39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42920956 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.42906304 |
| 41 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42039783 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40542634 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40067706 |
| 44 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39425500 |
| 45 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.34567992 |
| 46 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32824865 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32651652 |
| 48 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.30062498 |
| 49 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.29908035 |
| 50 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.27859077 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24673774 |
| 52 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.22844370 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.22844370 |
| 54 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.22525944 |
| 55 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.22034501 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.20371576 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19045333 |
| 58 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19015217 |
| 59 | TBL1_22424771_ChIP-Seq_293T_Human | 1.18493168 |
| 60 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.16137123 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15948368 |
| 62 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.15245813 |
| 63 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14640760 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13450274 |
| 65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12968072 |
| 66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12051511 |
| 67 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11884316 |
| 68 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10005737 |
| 69 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.09403706 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09361795 |
| 71 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.08262683 |
| 72 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.07466784 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05735312 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05692171 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04953321 |
| 76 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04190807 |
| 77 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00839364 |
| 78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00467056 |
| 79 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00446862 |
| 80 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99839996 |
| 81 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99061254 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98995468 |
| 83 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.96358829 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95252791 |
| 85 | NFYA_21822215_ChIP-Seq_K562_Human | 0.93986578 |
| 86 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92253666 |
| 87 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91138338 |
| 88 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.91128368 |
| 89 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.91103550 |
| 90 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.90200384 |
| 91 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90163004 |
| 92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.89355856 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89083886 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87822629 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87588596 |
| 96 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87107403 |
| 97 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86604200 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86231823 |
| 99 | NFYB_21822215_ChIP-Seq_K562_Human | 0.85541328 |
| 100 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.84959887 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84718007 |
| 102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83619303 |
| 103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83414598 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83398519 |
| 105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82840476 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82792649 |
| 107 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.82446732 |
| 108 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.79791245 |
| 109 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.79602475 |
| 110 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.78370784 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.78267718 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78144714 |
| 113 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.77094181 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76905704 |
| 115 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76060721 |
| 116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75754814 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75754814 |
| 118 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.75263657 |
| 119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.74088212 |
| 120 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.73816858 |
| 121 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.73496334 |
| 122 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71289089 |
| 123 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.70854156 |
| 124 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.69968272 |
| 125 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69217026 |
| 126 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69086002 |
| 127 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.67990048 |
| 128 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67374862 |
| 129 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66561478 |
| 130 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.64660129 |
| 131 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62404357 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.61980981 |
| 133 | ATF3_27146783_Chip-Seq_COLON_Human | 0.61789123 |
| 134 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.61572988 |
| 135 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.61085915 |
| 136 | CJUN_26792858_Chip-Seq_BT549_Human | 0.61033972 |
| 137 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.60396516 |
| 138 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.59599759 |
| 139 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.58137781 |
| 140 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56679505 |
| 141 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.56281385 |
| 142 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.54942612 |
| 143 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.54553600 |
| 144 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.54478688 |
| 145 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.54334904 |
| 146 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.53689224 |
| 147 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52303510 |
| 148 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.52084870 |
| 149 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.52035350 |
| 150 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.51489971 |
| 151 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50423634 |
| 152 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.48620281 |
| 153 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.48437239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 6.02207266 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.45325199 |
| 3 | MP0004215_abnormal_myocardial_fiber | 4.30880479 |
| 4 | MP0004036_abnormal_muscle_relaxation | 4.06270361 |
| 5 | MP0005330_cardiomyopathy | 3.94932279 |
| 6 | MP0000751_myopathy | 3.72717224 |
| 7 | MP0008775_abnormal_heart_ventricle | 3.61355454 |
| 8 | MP0003646_muscle_fatigue | 3.38400668 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.13423431 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.97341315 |
| 11 | MP0005360_urolithiasis | 2.81293443 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.80925412 |
| 13 | MP0000749_muscle_degeneration | 2.79992790 |
| 14 | MP0005385_cardiovascular_system_phenoty | 2.67936357 |
| 15 | MP0001544_abnormal_cardiovascular_syste | 2.67936357 |
| 16 | MP0003137_abnormal_impulse_conducting | 2.65235915 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.62857148 |
| 18 | MP0006138_congestive_heart_failure | 2.57600480 |
| 19 | * MP0010630_abnormal_cardiac_muscle | 2.52400812 |
| 20 | MP0005503_abnormal_tendon_morphology | 2.39884071 |
| 21 | MP0003828_pulmonary_edema | 2.38372652 |
| 22 | MP0004130_abnormal_muscle_cell | 2.37798993 |
| 23 | MP0005620_abnormal_muscle_contractility | 2.35877796 |
| 24 | MP0005365_abnormal_bile_salt | 2.28614471 |
| 25 | MP0008004_abnormal_stomach_pH | 2.24062910 |
| 26 | * MP0004085_abnormal_heartbeat | 2.21735620 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 2.19365634 |
| 28 | MP0005451_abnormal_body_composition | 2.16963473 |
| 29 | MP0004484_altered_response_of | 1.94696631 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.92594551 |
| 31 | MP0002127_abnormal_cardiovascular_syste | 1.88962640 |
| 32 | MP0004510_myositis | 1.87509782 |
| 33 | MP0000750_abnormal_muscle_regeneration | 1.85980551 |
| 34 | MP0002106_abnormal_muscle_physiology | 1.84380100 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.84206421 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.81877568 |
| 37 | MP0002269_muscular_atrophy | 1.81005230 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.66950545 |
| 39 | MP0003567_abnormal_fetal_cardiomyocyte | 1.60769110 |
| 40 | MP0003252_abnormal_bile_duct | 1.48304262 |
| 41 | MP0005369_muscle_phenotype | 1.43501023 |
| 42 | MP0009840_abnormal_foam_cell | 1.41078031 |
| 43 | MP0005332_abnormal_amino_acid | 1.39046280 |
| 44 | MP0000747_muscle_weakness | 1.35938960 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.33065948 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.31487265 |
| 47 | MP0005083_abnormal_biliary_tract | 1.28726822 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.24327497 |
| 49 | MP0002295_abnormal_pulmonary_circulatio | 1.23237570 |
| 50 | MP0000759_abnormal_skeletal_muscle | 1.21692680 |
| 51 | MP0004233_abnormal_muscle_weight | 1.15799222 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.15341591 |
| 53 | MP0003195_calcinosis | 1.14495127 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.12706587 |
| 55 | MP0001661_extended_life_span | 1.12350996 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.12200383 |
| 57 | * MP0000266_abnormal_heart_morphology | 1.09619050 |
| 58 | MP0003279_aneurysm | 1.07355042 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.07213383 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.05624861 |
| 61 | MP0004272_abnormal_basement_membrane | 1.03467645 |
| 62 | MP0005165_increased_susceptibility_to | 1.02458642 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.01745815 |
| 64 | MP0009384_cardiac_valve_regurgitation | 1.01489655 |
| 65 | MP0000013_abnormal_adipose_tissue | 0.99712934 |
| 66 | MP0000343_altered_response_to | 0.96214945 |
| 67 | MP0000230_abnormal_systemic_arterial | 0.93467654 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92859452 |
| 69 | MP0002128_abnormal_blood_circulation | 0.89874655 |
| 70 | MP0003566_abnormal_cell_adhesion | 0.86448237 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 0.86018843 |
| 72 | MP0000609_abnormal_liver_physiology | 0.85294195 |
| 73 | MP0005266_abnormal_metabolism | 0.80519526 |
| 74 | MP0001666_abnormal_nutrient_absorption | 0.78743556 |
| 75 | MP0000767_abnormal_smooth_muscle | 0.77661271 |
| 76 | MP0005670_abnormal_white_adipose | 0.77335123 |
| 77 | MP0001958_emphysema | 0.74993098 |
| 78 | MP0008874_decreased_physiological_sensi | 0.71929071 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 0.69386783 |
| 80 | MP0005409_darkened_coat_color | 0.68735506 |
| 81 | MP0003045_fibrosis | 0.67698482 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.66060807 |
| 83 | MP0009697_abnormal_copulation | 0.64953630 |
| 84 | MP0005375_adipose_tissue_phenotype | 0.62239623 |
| 85 | MP0009643_abnormal_urine_homeostasis | 0.62162905 |
| 86 | MP0001879_abnormal_lymphatic_vessel | 0.60802421 |
| 87 | MP0002234_abnormal_pharynx_morphology | 0.60214799 |
| 88 | MP0008438_abnormal_cutaneous_collagen | 0.59607000 |
| 89 | MP0001784_abnormal_fluid_regulation | 0.59564263 |
| 90 | MP0002971_abnormal_brown_adipose | 0.57256706 |
| 91 | MP0001299_abnormal_eye_distance/ | 0.56882436 |
| 92 | MP0001348_abnormal_lacrimal_gland | 0.55402963 |
| 93 | MP0003122_maternal_imprinting | 0.55339651 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.51564544 |
| 95 | MP0005535_abnormal_body_temperature | 0.50857687 |
| 96 | MP0005187_abnormal_penis_morphology | 0.50494774 |
| 97 | MP0000598_abnormal_liver_morphology | 0.48819551 |
| 98 | MP0005508_abnormal_skeleton_morphology | 0.46847688 |
| 99 | MP0001614_abnormal_blood_vessel | 0.45642546 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.45390492 |
| 101 | MP0005623_abnormal_meninges_morphology | 0.44875274 |
| 102 | MP0005275_abnormal_skin_tensile | 0.44866185 |
| 103 | MP0009763_increased_sensitivity_to | 0.43630940 |
| 104 | MP0002088_abnormal_embryonic_growth/wei | 0.43208994 |
| 105 | MP0002108_abnormal_muscle_morphology | 0.43053283 |
| 106 | MP0003984_embryonic_growth_retardation | 0.40956986 |
| 107 | MP0003091_abnormal_cell_migration | 0.40933301 |
| 108 | MP0004043_abnormal_pH_regulation | 0.40878627 |
| 109 | MP0000249_abnormal_blood_vessel | 0.40562516 |
| 110 | * MP0002925_abnormal_cardiovascular_devel | 0.40217342 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.40188980 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.40094943 |
| 113 | MP0003186_abnormal_redox_activity | 0.39645530 |
| 114 | MP0009642_abnormal_blood_homeostasis | 0.38218986 |
| 115 | MP0001727_abnormal_embryo_implantation | 0.36455693 |
| 116 | MP0003948_abnormal_gas_homeostasis | 0.35169579 |
| 117 | MP0000733_abnormal_muscle_development | 0.33881404 |
| 118 | MP0002933_joint_inflammation | 0.31749598 |
| 119 | MP0005023_abnormal_wound_healing | 0.30843199 |
| 120 | MP0005390_skeleton_phenotype | 0.29412927 |
| 121 | MP0003634_abnormal_glial_cell | 0.29215688 |
| 122 | MP0005164_abnormal_response_to | 0.26959235 |
| 123 | MP0005386_behavior/neurological_phenoty | 0.26648181 |
| 124 | MP0004924_abnormal_behavior | 0.26648181 |
| 125 | MP0001533_abnormal_skeleton_physiology | 0.26066381 |
| 126 | MP0000163_abnormal_cartilage_morphology | 0.25560322 |
| 127 | MP0002998_abnormal_bone_remodeling | 0.24684735 |
| 128 | MP0002115_abnormal_skeleton_extremities | 0.24502390 |
| 129 | MP0009115_abnormal_fat_cell | 0.24002573 |
| 130 | MP0009250_abnormal_appendicular_skeleto | 0.21915219 |
| 131 | MP0002877_abnormal_melanocyte_morpholog | 0.21781943 |
| 132 | MP0001730_embryonic_growth_arrest | 0.21021240 |
| 133 | MP0002089_abnormal_postnatal_growth/wei | 0.20560596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.27259758 |
| 2 | Ventricular tachycardia (HP:0004756) | 6.07952934 |
| 3 | Bradycardia (HP:0001662) | 5.92484659 |
| 4 | Atrial fibrillation (HP:0005110) | 5.66639867 |
| 5 | Primary atrial arrhythmia (HP:0001692) | 5.27416087 |
| 6 | Supraventricular tachycardia (HP:0004755) | 5.09309060 |
| 7 | Supraventricular arrhythmia (HP:0005115) | 4.99903168 |
| 8 | Lipoatrophy (HP:0100578) | 4.90797377 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.86596515 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 4.67570141 |
| 11 | Myoglobinuria (HP:0002913) | 4.64521772 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 4.61910338 |
| 13 | Syncope (HP:0001279) | 4.61060043 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.57340562 |
| 15 | Subaortic stenosis (HP:0001682) | 4.57340562 |
| 16 | Hypoplastic left heart (HP:0004383) | 4.55178906 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 4.34771007 |
| 18 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.31834504 |
| 19 | Palpitations (HP:0001962) | 4.29954358 |
| 20 | Hypoglycemic coma (HP:0001325) | 4.24907206 |
| 21 | Exercise-induced myalgia (HP:0003738) | 4.24415191 |
| 22 | Dilated cardiomyopathy (HP:0001644) | 4.09886946 |
| 23 | Wrist flexion contracture (HP:0001239) | 4.07796340 |
| 24 | Anomalous pulmonary venous return (HP:0010772) | 4.07075956 |
| 25 | Ventricular arrhythmia (HP:0004308) | 4.03050569 |
| 26 | Partial duplication of thumb phalanx (HP:0009944) | 3.97105979 |
| 27 | Aplasia of the musculature (HP:0100854) | 3.84585659 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.74898965 |
| 29 | Muscle fiber splitting (HP:0003555) | 3.69524209 |
| 30 | Prolonged QT interval (HP:0001657) | 3.68653477 |
| 31 | Atrioventricular block (HP:0001678) | 3.61948179 |
| 32 | Hypoplastic heart (HP:0001961) | 3.60305767 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.55707210 |
| 34 | Abnormality of the pulmonary veins (HP:0011718) | 3.55248517 |
| 35 | Ketoacidosis (HP:0001993) | 3.51588697 |
| 36 | Rhabdomyolysis (HP:0003201) | 3.48469968 |
| 37 | Hyporeflexia of lower limbs (HP:0002600) | 3.46826006 |
| 38 | Partial duplication of the phalanx of hand (HP:0009999) | 3.45080924 |
| 39 | Heart block (HP:0012722) | 3.36857658 |
| 40 | Ketosis (HP:0001946) | 3.30081198 |
| 41 | Ragged-red muscle fibers (HP:0003200) | 3.30055330 |
| 42 | Hyperammonemia (HP:0001987) | 3.28504089 |
| 43 | Congenital malformation of the right heart (HP:0011723) | 3.28192385 |
| 44 | Double outlet right ventricle (HP:0001719) | 3.28192385 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.25746853 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 3.25746853 |
| 47 | Bundle branch block (HP:0011710) | 3.23344117 |
| 48 | Ventricular fibrillation (HP:0001663) | 3.20746472 |
| 49 | Abnormal atrioventricular conduction (HP:0005150) | 3.14382780 |
| 50 | Deep venous thrombosis (HP:0002625) | 3.13439280 |
| 51 | Hepatic necrosis (HP:0002605) | 3.11829866 |
| 52 | Distal lower limb amyotrophy (HP:0008944) | 3.09447466 |
| 53 | Cerebral edema (HP:0002181) | 3.02077387 |
| 54 | EMG: myopathic abnormalities (HP:0003458) | 2.99185072 |
| 55 | Bulbar palsy (HP:0001283) | 2.88402707 |
| 56 | Abnormality of the tricuspid valve (HP:0001702) | 2.83010760 |
| 57 | Rimmed vacuoles (HP:0003805) | 2.82732337 |
| 58 | Conjunctival hamartoma (HP:0100780) | 2.72860668 |
| 59 | Increased connective tissue (HP:0009025) | 2.70758337 |
| 60 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.70473622 |
| 61 | Hyperglycinuria (HP:0003108) | 2.69995653 |
| 62 | Intrahepatic cholestasis (HP:0001406) | 2.68586717 |
| 63 | Generalized aminoaciduria (HP:0002909) | 2.62099164 |
| 64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.61880623 |
| 65 | Acute encephalopathy (HP:0006846) | 2.61288600 |
| 66 | Abnormal EKG (HP:0003115) | 2.59049040 |
| 67 | Xanthomatosis (HP:0000991) | 2.57586076 |
| 68 | Acute necrotizing encephalopathy (HP:0006965) | 2.57144509 |
| 69 | Abnormality of the foot musculature (HP:0001436) | 2.56932465 |
| 70 | Hypoalphalipoproteinemia (HP:0003233) | 2.56273205 |
| 71 | Proximal amyotrophy (HP:0007126) | 2.53255588 |
| 72 | Foot dorsiflexor weakness (HP:0009027) | 2.50145703 |
| 73 | Neck muscle weakness (HP:0000467) | 2.49967676 |
| 74 | Palmoplantar keratoderma (HP:0000982) | 2.49314482 |
| 75 | Arthropathy (HP:0003040) | 2.48491086 |
| 76 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.48040821 |
| 77 | Patent foramen ovale (HP:0001655) | 2.47975908 |
| 78 | Abnormality of glycine metabolism (HP:0010895) | 2.47618340 |
| 79 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.47618340 |
| 80 | Hyperlipoproteinemia (HP:0010980) | 2.42233354 |
| 81 | Left ventricular hypertrophy (HP:0001712) | 2.42224018 |
| 82 | Pulmonary artery stenosis (HP:0004415) | 2.40294629 |
| 83 | Lower limb amyotrophy (HP:0007210) | 2.40015057 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 2.37991973 |
| 85 | Neoplasm of the adrenal gland (HP:0100631) | 2.36292887 |
| 86 | Increased serum pyruvate (HP:0003542) | 2.32719549 |
| 87 | Abnormality of glycolysis (HP:0004366) | 2.32719549 |
| 88 | Areflexia of lower limbs (HP:0002522) | 2.31829468 |
| 89 | Hepatocellular necrosis (HP:0001404) | 2.29989423 |
| 90 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.27535136 |
| 91 | Metabolic acidosis (HP:0001942) | 2.26367215 |
| 92 | Increased muscle lipid content (HP:0009058) | 2.25731914 |
| 93 | Complete atrioventricular canal defect (HP:0001674) | 2.25726916 |
| 94 | Nausea (HP:0002018) | 2.25171176 |
| 95 | Difficulty climbing stairs (HP:0003551) | 2.25007786 |
| 96 | Lymphangioma (HP:0100764) | 2.24884439 |
| 97 | Sudden cardiac death (HP:0001645) | 2.24811327 |
| 98 | Pheochromocytoma (HP:0002666) | 2.23483680 |
| 99 | Skin nodule (HP:0200036) | 2.22701254 |
| 100 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.22672643 |
| 101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.22615664 |
| 102 | Hypolipoproteinemia (HP:0010981) | 2.21172294 |
| 103 | Dysmetric saccades (HP:0000641) | 2.17352149 |
| 104 | Hyperglycinemia (HP:0002154) | 2.17069890 |
| 105 | Complement deficiency (HP:0004431) | 2.14394822 |
| 106 | Myotonia (HP:0002486) | 2.12646152 |
| 107 | Progressive macrocephaly (HP:0004481) | 2.11983635 |
| 108 | Cholelithiasis (HP:0001081) | 2.11408150 |
| 109 | Prolonged partial thromboplastin time (HP:0003645) | 2.10695033 |
| 110 | EMG: neuropathic changes (HP:0003445) | 2.10620252 |
| 111 | Lethargy (HP:0001254) | 2.10068024 |
| 112 | Proximal tubulopathy (HP:0000114) | 2.08323777 |
| 113 | Lactic acidosis (HP:0003128) | 2.07415264 |
| 114 | Increased CSF lactate (HP:0002490) | 2.07300835 |
| 115 | Multiple enchondromatosis (HP:0005701) | 2.07089810 |
| 116 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.03266621 |
| 117 | Hypobetalipoproteinemia (HP:0003563) | 2.02373004 |
| 118 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.02204685 |
| 119 | Mitochondrial inheritance (HP:0001427) | 2.01233727 |
| 120 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.98453144 |
| 121 | Cavernous hemangioma (HP:0001048) | 1.98380015 |
| 122 | Congestive heart failure (HP:0001635) | 1.96709522 |
| 123 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.96679189 |
| 124 | Abnormal gallbladder morphology (HP:0012437) | 1.96539459 |
| 125 | Renal cortical cysts (HP:0000803) | 1.95527966 |
| 126 | Hyperglycemia (HP:0003074) | 1.94599843 |
| 127 | Distal lower limb muscle weakness (HP:0009053) | 1.94499182 |
| 128 | Hamartoma of the eye (HP:0010568) | 1.93790166 |
| 129 | Duplication of thumb phalanx (HP:0009942) | 1.93488130 |
| 130 | Increased intramyocellular lipid droplets (HP:0012240) | 1.92936285 |
| 131 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.92719270 |
| 132 | Neuroendocrine neoplasm (HP:0100634) | 1.92671367 |
| 133 | Generalized muscle weakness (HP:0003324) | 1.92639880 |
| 134 | Difficulty running (HP:0009046) | 1.90997738 |
| 135 | Neoplasm of head and neck (HP:0012288) | 1.90231739 |
| 136 | Esophageal neoplasm (HP:0100751) | 1.90231739 |
| 137 | Steppage gait (HP:0003376) | 1.83192904 |
| 138 | Preauricular pit (HP:0004467) | 1.82134097 |
| 139 | Periauricular skin pits (HP:0100277) | 1.82134097 |
| 140 | Transposition of the great arteries (HP:0001669) | 1.81066814 |
| 141 | Abnormal connection of the cardiac segments (HP:0011545) | 1.81066814 |
| 142 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.81066814 |
| 143 | Atrioventricular canal defect (HP:0006695) | 1.76873110 |
| 144 | Truncus arteriosus (HP:0001660) | 1.74862456 |
| 145 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.72694109 |
| 146 | Limb-girdle muscle atrophy (HP:0003797) | 1.71292325 |
| 147 | Abnormality of the thoracic spine (HP:0100711) | 1.70671225 |
| 148 | Muscular dystrophy (HP:0003560) | 1.66347906 |
| 149 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.65309384 |
| 150 | Skin pits (HP:0100276) | 1.63126255 |
| 151 | Abnormality of complement system (HP:0005339) | 1.60662657 |
| 152 | Aneurysm (HP:0002617) | 1.58884526 |
| 153 | Mitral stenosis (HP:0001718) | 1.58091272 |
| 154 | Vertebral arch anomaly (HP:0008438) | 1.57411780 |
| 155 | Gowers sign (HP:0003391) | 1.55710942 |
| 156 | Spontaneous hematomas (HP:0007420) | 1.53413753 |
| 157 | Stroke (HP:0001297) | 1.51795517 |
| 158 | Vascular calcification (HP:0004934) | 1.51519075 |
| 159 | Fatigable weakness (HP:0003473) | 1.51513993 |
| 160 | Abnormality of the neuromuscular junction (HP:0003398) | 1.51513993 |
| 161 | Hematochezia (HP:0002573) | 1.47040631 |
| 162 | Muscle fiber inclusion bodies (HP:0100299) | 1.44104109 |
| 163 | Scapular winging (HP:0003691) | 1.43808092 |
| 164 | Esophageal varix (HP:0002040) | 1.43340493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PKN2 | 5.03657874 |
| 2 | TTN | 4.98948871 |
| 3 | OBSCN | 4.05204192 |
| 4 | MYLK | 3.95490107 |
| 5 | LMTK2 | 3.74325278 |
| 6 | PDK3 | 3.32099672 |
| 7 | PDK4 | 3.32099672 |
| 8 | BCKDK | 3.23455530 |
| 9 | TRIB3 | 3.09209870 |
| 10 | STK24 | 2.84917980 |
| 11 | PHKG1 | 2.83190359 |
| 12 | PHKG2 | 2.83190359 |
| 13 | TIE1 | 2.69254056 |
| 14 | NEK1 | 2.44108768 |
| 15 | DMPK | 2.42701020 |
| 16 | FLT3 | 1.97533099 |
| 17 | PIK3CA | 1.94701442 |
| 18 | PDK2 | 1.92848076 |
| 19 | PINK1 | 1.51801289 |
| 20 | INSRR | 1.48694672 |
| 21 | CDC42BPA | 1.39810472 |
| 22 | ILK | 1.37086458 |
| 23 | MARK1 | 1.30163248 |
| 24 | PAK3 | 1.28566203 |
| 25 | GRK7 | 1.25618077 |
| 26 | MAP3K6 | 1.19982367 |
| 27 | PRKD1 | 1.18073457 |
| 28 | KDR | 1.07750366 |
| 29 | STK38L | 1.06896765 |
| 30 | MAP3K7 | 1.06265481 |
| 31 | FGFR4 | 1.05949715 |
| 32 | DAPK3 | 1.04401244 |
| 33 | SIK1 | 1.03951310 |
| 34 | WNK4 | 1.03401714 |
| 35 | EPHA4 | 1.02847175 |
| 36 | ZAK | 1.01944443 |
| 37 | CAMK2D | 0.98281507 |
| 38 | EPHA3 | 0.98043507 |
| 39 | TGFBR1 | 0.97146318 |
| 40 | PRKAA2 | 0.96402796 |
| 41 | SGK2 | 0.94391928 |
| 42 | TRPM7 | 0.92373653 |
| 43 | ROCK1 | 0.92280185 |
| 44 | MUSK | 0.92220710 |
| 45 | MAPK12 | 0.91187526 |
| 46 | CAMK4 | 0.89571330 |
| 47 | STK4 | 0.87607752 |
| 48 | PRPF4B | 0.87181894 |
| 49 | RIPK1 | 0.83970923 |
| 50 | MAPK4 | 0.82861656 |
| 51 | NLK | 0.81686715 |
| 52 | PRKAA1 | 0.80059354 |
| 53 | PTK6 | 0.78963218 |
| 54 | TGFBR2 | 0.78629284 |
| 55 | NEK9 | 0.76652674 |
| 56 | MAP2K3 | 0.75934156 |
| 57 | PTK2B | 0.74519669 |
| 58 | CSK | 0.72714786 |
| 59 | CAMK2A | 0.69692010 |
| 60 | LATS1 | 0.68209062 |
| 61 | MAP3K5 | 0.67871825 |
| 62 | SGK223 | 0.67583694 |
| 63 | SGK494 | 0.67583694 |
| 64 | MAP3K3 | 0.66906275 |
| 65 | CAMK1 | 0.65694315 |
| 66 | STK39 | 0.63624823 |
| 67 | RPS6KA2 | 0.61919401 |
| 68 | MAP3K10 | 0.58597494 |
| 69 | PDGFRA | 0.57105703 |
| 70 | UHMK1 | 0.53883552 |
| 71 | ITK | 0.53021760 |
| 72 | MAP2K1 | 0.52154572 |
| 73 | PRKACG | 0.51068341 |
| 74 | EPHB1 | 0.50641794 |
| 75 | PKN1 | 0.50215633 |
| 76 | MAPK11 | 0.49972709 |
| 77 | CAMK2B | 0.49601225 |
| 78 | STK11 | 0.48970626 |
| 79 | STK38 | 0.48935504 |
| 80 | DDR2 | 0.46531088 |
| 81 | FGFR3 | 0.46375173 |
| 82 | RET | 0.45349325 |
| 83 | ERN1 | 0.43984538 |
| 84 | MAP2K4 | 0.43898088 |
| 85 | WNK1 | 0.43661424 |
| 86 | PRKACB | 0.43248180 |
| 87 | KSR2 | 0.41308437 |
| 88 | ZAP70 | 0.41090060 |
| 89 | MAPKAPK3 | 0.40398800 |
| 90 | PDK1 | 0.40213657 |
| 91 | CAMK2G | 0.39817280 |
| 92 | LIMK1 | 0.39633929 |
| 93 | MELK | 0.37841488 |
| 94 | MARK2 | 0.37726355 |
| 95 | PDGFRB | 0.36240994 |
| 96 | PRKACA | 0.35960099 |
| 97 | JAK2 | 0.35615448 |
| 98 | RPS6KC1 | 0.34332421 |
| 99 | RPS6KL1 | 0.34332421 |
| 100 | LRRK2 | 0.34327146 |
| 101 | PDPK1 | 0.34232723 |
| 102 | JAK1 | 0.32815581 |
| 103 | PRKD2 | 0.31926367 |
| 104 | PRKD3 | 0.31212697 |
| 105 | PRKCE | 0.31002065 |
| 106 | LATS2 | 0.30772140 |
| 107 | ICK | 0.29857288 |
| 108 | ROCK2 | 0.29757778 |
| 109 | HIPK2 | 0.29671065 |
| 110 | TYK2 | 0.28514584 |
| 111 | FGFR1 | 0.27350386 |
| 112 | PRKCQ | 0.26710431 |
| 113 | RPS6KA6 | 0.26188430 |
| 114 | FES | 0.25937489 |
| 115 | PRKG2 | 0.25026029 |
| 116 | CDK4 | 0.23062262 |
| 117 | AKT2 | 0.22945809 |
| 118 | AKT1 | 0.21907667 |
| 119 | MAPK7 | 0.21088214 |
| 120 | ADRBK1 | 0.20097713 |
| 121 | RPS6KA3 | 0.18808492 |
| 122 | FER | 0.18758700 |
| 123 | SRC | 0.18445261 |
| 124 | MET | 0.18333222 |
| 125 | ERBB4 | 0.18086411 |
| 126 | FYN | 0.17139153 |
| 127 | PAK2 | 0.16876098 |
| 128 | SGK3 | 0.16436429 |
| 129 | PRKCH | 0.16430923 |
| 130 | CDK5 | 0.16334027 |
| 131 | EPHB2 | 0.16203498 |
| 132 | MTOR | 0.16110023 |
| 133 | RPS6KA1 | 0.15596920 |
| 134 | PRKG1 | 0.14543477 |
| 135 | RPS6KA5 | 0.14451662 |
| 136 | RAF1 | 0.14167620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.63457943 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.99196799 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.89491018 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.57005199 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.30296387 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.02108646 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.77352130 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.67631861 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62365516 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.42967386 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.32588911 |
| 12 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.29648169 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23425823 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.20566336 |
| 15 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.19651586 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.05238893 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04675585 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.88908621 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.83148031 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.81971519 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.77217353 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.76439167 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.75806238 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71247629 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71027029 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.59566429 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.56963857 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56026975 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47141394 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 1.46501219 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.45724240 |
| 32 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.39570302 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.35837941 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.35807322 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34115164 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.33916803 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.32905382 |
| 38 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.31609523 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.29588203 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29481500 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24103814 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08363236 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.03217559 |
| 44 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.02285298 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99080771 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.97504151 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 0.96330753 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94164528 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 0.92186934 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90287084 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88422776 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87459407 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87216362 |
| 54 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.86695032 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.83301871 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81344410 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 0.81082633 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80359583 |
| 59 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.80284152 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76192467 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75342603 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.74877407 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74719396 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71851704 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71016564 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68975036 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67747537 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67600497 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67544537 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65994517 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.63071468 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62674268 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61324358 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59818110 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59531839 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58895238 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57433613 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57351344 |
| 79 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56798081 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56234101 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55681373 |
| 82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55645138 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55469660 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55391505 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55300757 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54945920 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54194286 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.53789576 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53243226 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52494092 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.52331034 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51293376 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50926032 |
| 94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50897730 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50810820 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50171855 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.49615602 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47987297 |
| 99 | Taste transduction_Homo sapiens_hsa04742 | 0.47876984 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47797760 |
| 101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47482085 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44796583 |
| 103 | Morphine addiction_Homo sapiens_hsa05032 | 0.44390490 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43354305 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42502680 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42184852 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42142842 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40149829 |
| 109 | Cocaine addiction_Homo sapiens_hsa05030 | 0.40009827 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39637034 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39184685 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38882206 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38718752 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37530965 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36921360 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.35957243 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35722592 |
| 118 | Axon guidance_Homo sapiens_hsa04360 | 0.35433111 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33533370 |
| 120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31825208 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31690124 |
| 122 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30497939 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28085959 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.28068631 |
| 125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27009530 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26824184 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.24183833 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23755181 |
| 129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.23115210 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22255998 |
| 131 | Melanogenesis_Homo sapiens_hsa04916 | 0.20554746 |
| 132 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.17703245 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.16118788 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13919800 |
| 135 | Tight junction_Homo sapiens_hsa04530 | 0.13058775 |
| 136 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.12911434 |
| 137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.12877739 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.09923060 |
| 139 | Sulfur relay system_Homo sapiens_hsa04122 | 0.09831834 |
| 140 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.06062381 |
| 141 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.05721505 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.05179061 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.05156712 |
| 144 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.02360332 |
| 145 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.02144434 |
| 146 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.01196392 |
| 147 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | -0.0242364 |
| 148 | Adherens junction_Homo sapiens_hsa04520 | -0.0219040 |
| 149 | Renin secretion_Homo sapiens_hsa04924 | -0.0141884 |

